{"id":5639,"date":"2018-10-04T08:30:57","date_gmt":"2018-10-04T12:30:57","guid":{"rendered":"https:\/\/www.stockcalc.com\/blog\/BrianD\/?p=5639"},"modified":"2018-10-04T08:30:57","modified_gmt":"2018-10-04T12:30:57","slug":"total-totnys-and-vertex-pharmaceuticals-vrtxnas-upgraded","status":"publish","type":"post","link":"https:\/\/www.stockcalc.com\/blog\/BrianD\/2018\/10\/04\/total-totnys-and-vertex-pharmaceuticals-vrtxnas-upgraded\/","title":{"rendered":"Total (TOT:NYS) and Vertex Pharmaceuticals (VRTX:NAS) Upgraded"},"content":{"rendered":"

Stockcalc – Free Trial<\/h4>\n

Have a free look inside the StockCalc website at www.stockcalc.com<\/a><\/p>\n

\n
\n<\/hr>\n

I have used the analysis tools on the website stockcalc.com<\/a> to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com\/toppicks.aspx<\/a>.<\/p>\n

Upgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX<\/h4>\n

Today we are looking at companies whose share price has been upgraded by at least one analyst in the last few days.<\/p>\n

Why Do Companies Get Upgraded?<\/h5>\n

Companies can get upgraded for a number of reasons, but primarily due to improved future earnings potential due to new contracts, new products, cost savings or restructuring.<\/p>\n

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.<\/p>\n

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX<\/h4>\n

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.<\/p>\n

New York Stock Exchange<\/h6>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Symbol<\/th>\nName<\/th>\nBuy<\/th>\nOut Perform<\/th>\nHold<\/th>\nUnder Perform<\/th>\nSell<\/th>\nNo Opinion<\/th>\nMean Rating<\/th>\nPrev Mean Rating<\/th>\nMean Label<\/th>\n<\/tr>\n
TOT<\/td>\nTotal SA<\/td>\n3<\/td>\n1<\/td>\n3<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n4.0000<\/td>\n3.8333<\/td>\nOutperform<\/td>\n<\/tr>\n
BCS<\/td>\nBarclays PLC<\/td>\n3<\/td>\n1<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n4.7500<\/td>\n4.5000<\/td>\nBuy<\/td>\n<\/tr>\n
NOK<\/td>\nNokia Oyj<\/td>\n3<\/td>\n1<\/td>\n3<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n4.0000<\/td>\n3.8571<\/td>\nOutperform<\/td>\n<\/tr>\n
EFX<\/td>\nEquifax Inc<\/td>\n9<\/td>\n2<\/td>\n2<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n4.5385<\/td>\n4.5000<\/td>\nBuy<\/td>\n<\/tr>\n
TRU<\/td>\nTransUnion<\/td>\n2<\/td>\n0<\/td>\n0<\/td>\n1<\/td>\n0<\/td>\n0<\/td>\n4.0000<\/td>\n3.5000<\/td>\nOutperform<\/td>\n<\/tr>\n
ECA<\/td>\nEncana Corp<\/td>\n13<\/td>\n5<\/td>\n1<\/td>\n1<\/td>\n0<\/td>\n0<\/td>\n4.5000<\/td>\n4.4737<\/td>\nOutperform<\/td>\n<\/tr>\n
NVR<\/td>\nNVR Inc<\/td>\n0<\/td>\n0<\/td>\n2<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n3.0000<\/td>\n2.5000<\/td>\nHold<\/td>\n<\/tr>\n
FDS<\/td>\nFactSet Research Systems Inc<\/td>\n0<\/td>\n0<\/td>\n5<\/td>\n0<\/td>\n2<\/td>\n0<\/td>\n2.4286<\/td>\n2.3333<\/td>\nUnderperform<\/td>\n<\/tr>\n
PHM<\/td>\nPulteGroup Inc<\/td>\n3<\/td>\n1<\/td>\n2<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n4.1667<\/td>\n4.0000<\/td>\nOutperform<\/td>\n<\/tr>\n
ARGO<\/td>\nArgo Group International Holdings Ltd<\/td>\n1<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n5.0000<\/td>\n1.0000<\/td>\nBuy<\/td>\n<\/tr>\n
CLS<\/td>\nCelestica Inc<\/td>\n3<\/td>\n0<\/td>\n8<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n3.5455<\/td>\n3.4000<\/td>\nOutperform<\/td>\n<\/tr>\n<\/table>\n
Toronto Stock Exchange<\/h6>\n\n\n\n\n\n\n\n\n
Symbol<\/th>\nName<\/th>\nBuy<\/th>\nOut Perform<\/th>\nHold<\/th>\nUnder Perform<\/th>\nSell<\/th>\nNo Opinion<\/th>\nMean Rating<\/th>\nPrev Mean Rating<\/th>\nMean Label<\/th>\n<\/tr>\n
ECA<\/td>\nEncana Corp<\/td>\n13<\/td>\n5<\/td>\n1<\/td>\n1<\/td>\n0<\/td>\n0<\/td>\n4.5000<\/td>\n4.4737<\/td>\nOutperform<\/td>\n<\/tr>\n
CLS<\/td>\nCelestica Inc<\/td>\n3<\/td>\n0<\/td>\n8<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n3.5455<\/td>\n3.4000<\/td>\nOutperform<\/td>\n<\/tr>\n
HRX<\/td>\nHeroux-Devtek Inc<\/td>\n1<\/td>\n2<\/td>\n4<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n3.5714<\/td>\n3.3333<\/td>\nOutperform<\/td>\n<\/tr>\n
YGR<\/td>\nYangarra Resources Ltd<\/td>\n6<\/td>\n5<\/td>\n1<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n4.4167<\/td>\n4.3636<\/td>\nOutperform<\/td>\n<\/tr>\n
BOS<\/td>\nAirboss of America Corp<\/td>\n0<\/td>\n2<\/td>\n3<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n3.4000<\/td>\n3.2000<\/td>\nHold<\/td>\n<\/tr>\n
ONC<\/td>\nOncolytics Biotech Inc<\/td>\n2<\/td>\n2<\/td>\n1<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n4.2000<\/td>\n4.0000<\/td>\nOutperform<\/td>\n<\/tr>\n<\/table>\n
NASDAQ<\/h6>\n\n\n\n\n\n\n\n\n\n\n\n
Symbol<\/th>\nName<\/th>\nBuy<\/th>\nOut Perform<\/th>\nHold<\/th>\nUnder Perform<\/th>\nSell<\/th>\nNo Opinion<\/th>\nMean Rating<\/th>\nPrev Mean Rating<\/th>\nMean Label<\/th>\n<\/tr>\n
GILD<\/td>\nGilead Sciences Inc<\/td>\n4<\/td>\n0<\/td>\n4<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n4.0000<\/td>\n3.8571<\/td>\nOutperform<\/td>\n<\/tr>\n
VRTX<\/td>\nVertex Pharmaceuticals Inc<\/td>\n5<\/td>\n0<\/td>\n3<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n4.2500<\/td>\n4.1429<\/td>\nOutperform<\/td>\n<\/tr>\n
INFO<\/td>\nIHS Markit Ltd<\/td>\n1<\/td>\n0<\/td>\n4<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n3.4000<\/td>\n3.0000<\/td>\nHold<\/td>\n<\/tr>\n
SRPT<\/td>\nSarepta Therapeutics Inc<\/td>\n4<\/td>\n0<\/td>\n1<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n4.6000<\/td>\n4.5000<\/td>\nBuy<\/td>\n<\/tr>\n
TSRO<\/td>\nTesaro Inc<\/td>\n3<\/td>\n0<\/td>\n2<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n4.2000<\/td>\n4.0000<\/td>\nOutperform<\/td>\n<\/tr>\n
PBYI<\/td>\nPuma Biotechnology Inc<\/td>\n1<\/td>\n0<\/td>\n1<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n4.0000<\/td>\n3.0000<\/td>\nOutperform<\/td>\n<\/tr>\n
AKRX<\/td>\nAkorn Inc<\/td>\n1<\/td>\n1<\/td>\n2<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n3.7500<\/td>\n3.6667<\/td>\nOutperform<\/td>\n<\/tr>\n
ONCY<\/td>\nOncolytics Biotech Inc<\/td>\n2<\/td>\n2<\/td>\n1<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n4.2000<\/td>\n4.0000<\/td>\nOutperform<\/td>\n<\/tr>\n
ADIL<\/td>\nAdial Pharmaceuticals Inc<\/td>\n1<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n0<\/td>\n5.0000<\/td>\n0.0000<\/td>\nBuy<\/td>\n<\/tr>\n<\/table>\n

Let’s look at a few companies…<\/h4>\n

Lets look at a couple of the companies on this list to get a better understanding of them.<\/p>\n

TOT:NYS Total<\/h6>\n

http:\/\/www.total.com<\/a>
\nTotal has 98277 employees and is headquartered in France.
\nTotal SA is an integrated oil and gas company. It is engaged in exploring, producing, refining oil and gas and related products.<\/p>\n

VRTX:NAS Vertex Pharmaceuticals<\/h6>\n

http:\/\/www.vrtx.com<\/a>
\nVertex Pharmaceuticals has 2300 employees and is headquartered in United States.
\nVertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets. Its products include SYMDEKO, ORKAMBI, and KALYDECO.<\/p>\n

Free Valuation<\/h4>\n

Run a valuation on any of the companies listed above at www.stockcalc.com\/valureport.aspx<\/a> or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports<\/a>.<\/p>\n

The content presented here is in part from the website stockcalc.com<\/a> and is provided on an as is<\/strong> or as available<\/strong> basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.<\/em><\/p>\n

<\/div>\n
\n

Wait! We want you to try StockCalc for<\/span><\/h2>\n

5 Free Days <\/h1>\n

Yes, I want to find out what my stocks are worth<\/span><\/a>
\n No, I don’t want to know the value of my stocks<\/span><\/a>\n <\/div>\n